The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Actors and Incentives in Cannabis Policy Change: an Interdisciplinary Approach to Legalization Processes in the United States and in Uruguay
1 UNIVERSIDADE DE SÃO PAULO INSTITUTO DE RELAÇÕES INTERNACIONAIS Fernanda Mena Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay São Paulo 2020 FERNANDA MELLO MENA 2 Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Original Version Ph.D. Thesis presented to the Graduate Program in International Relations at the International Relations Institute, Universidade de São Paulo, Brazil, to obtain the degree of Doctor in Science. Advisor: Prof. Dr. Leandro Piquet Carneiro São Paulo 2020 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. 3 Catalogação na Publicação* Instituto de Relações Internacionais da Universidade de São Paulo Mena, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay / Fernanda Mello Mena -- Orientador Leandro Piquet Carneiro. São Paulo: 2020. 195p. Tese (doutorado). Universidade de São Paulo. Instituto de Relações Internacionais. 1. Relações exteriores (História) – Brasil 2. Relações internacionais (História) - Brasil 3. Política externa – Brasil I. Mena, Fernanda II. Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay CDD 327.81 4 MENA, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Ph. D. Thesis presented to the International Relations Institute, at the University of São Paulo, Brazil, to obtain the degree of Doctor in Science. -
Extracts and Tinctures of Cannabis
WHO Expert Committee on Drug Dependence Critical Review …………….. Extracts and tinctures of cannabis This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization © World Health Organization 2018 All rights reserved. This is an advance copy distributed to the participants of the 41st Expert Committee on Drug Dependence, before it has been formally published by the World Health Organization. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. -
Methods to Assess Cannabis Consumption in Population Surveys
QHRXXX10.1177/1049732318820523Qualitative Health ResearchGoodman et al. 820523research-article2019 Research Article Qualitative Health Research 1 –9 Methods to Assess Cannabis © The Author(s) 2019 Article reuse guidelines: sagepub.com/journals-permissions Consumption in Population Surveys: DOI:https://doi.org/10.1177/1049732318820523 10.1177/1049732318820523 Results of Cognitive Interviewing journals.sagepub.com/home/qhr Samantha Goodman1 , Cesar Leos-Toro1, and David Hammond1 Abstract The Cannabis Act legalized the possession and sale of nonmedical cannabis in Canada on October 17, 2018. Evaluating the impact of cannabis legalization requires a more thorough understanding than is provided by most existing measures of cannabis use. The aim of this study was to pretest a range of cannabis consumption measures used in a population- based survey and to share insights gained in the process. Cognitive interviewing was conducted among 10 cannabis users aged ≥16 years. Comprehension and self-reporting of consumption types and amounts, sources of purchase, and cannabinoid levels were examined. Findings revealed areas for improvement in a number of survey items, including unclear wording and reference images. Identified issues were used to improve the survey for use in the International Cannabis Policy Study. The authors discuss important principles (e.g., use of visual cues, user-selected units, and time frames) that should be adopted when assessing cannabis use in population-based studies. Keywords cannabis; cognitive interview; prevalence; measurement; qualitative; Canada Background cannabis consumption in terms of the number of times cannabis is used within a particular month, day or week, Cannabis (also referred to as “marijuana,” “pot,” “weed,” or the typical amount used on each occasion (e.g., etc.) is the most frequently used illicit substance world- Canadian Cannabis Survey; Advanis, 2017). -
Why Medical Cannabis Is Still out of Patients' Reach—An Essay by David
BMJ 2019;365:l1903 doi: 10.1136/bmj.l1903 (Published 1 May 2019) Page 1 of 3 Feature FEATURE BMJ: first published as 10.1136/bmj.l1903 on 1 May 2019. Downloaded from ESSAY Why medical cannabis is still out of patients’ reach—an essay by David Nutt Cannabis has been used as a medicine for millennia, writes David Nutt, who charts its relatively recent prohibition, the effect on patients such as Billy Caldwell, and the failure of legal reform to make much difference David Nutt Edmond J Safra professor of neuropsychopharmacology Imperial College London, London W12 0NN, UK Cannabis is arguably the world’s oldest medicine, with evidence This report was relied on to control cannabis under the 1961 of such use from 3000 year old tombs in Egypt and Siberia. It United Nations Single Convention on Narcotic Drugs and had a place in Indian and Chinese medical writing from nearly amazingly persisted as the international medical guidance on as long ago. It didn’t enter the UK until the late 1600s, but by cannabis until 2018, being used as the justification by the World the 1800s it was widely used, sold over the counter as an Health Organization for keeping cannabis a schedule 1 http://www.bmj.com/ alcoholic tincture for problems such as tetanus and seizures. Its controlled drug till then. Even more absurdly, the 1934 report efficacy more broadly became apparent, and the definitive has been lost, so we can’t explore its evidential base or overview was published in the Lancet in 1890 by John Russell reasoning.3 1 Reynolds. -
Big-Catalogue-English-2020.Pdf
PAS CH SIO UT N D ® CATALOGUE English SEED COMPANY Feminized, autoflower and regular cannabis seeds AMSTERDAM, ESTABLISHED 1987 for recreational and medical use. Amsterdam - Maastricht YOUR PASSION OUR PASSION DUTCH PASSION 02 Contents Welcome to Dutch Passion Welcome to Dutch Passion 02 Dutch Passion was the second Cannabis Seed Company in the world, established in Amsterdam in 1987. It is our mission to supply Bestsellers 2019 02 the recreational and medical home grower with the highest quality cannabis products available in all countries where this is legally Regular, Feminized and Autoflower 03 allowed. Cannabinoids 03 Medical use of cannabis 03 After many years of dedication Dutch Passion remains a leading supplier of the world’s best cannabis genetics. Our experienced Super Sativa Seed Club 04 team do their utmost to maintain the quality of our existing varieties and constantly search for new ones from an extensive network Special Cannabinoids / THC-Victory 05 of worldwide sources. We supply thousands of retailers and seed distributors around the world. Dutch Outdoor 06 High Altitude 09 CBD Rich 10 Dutch Passion have never been afraid to upset conventional thinking; we invented feminized seeds in the 1990’s and more recently Latin America 13 have pioneered the introduction of 10-week Autoflower seeds which have helped make life even easier for the self-sufficient Classics 14 cannabis grower. CBD-rich medical cannabis genetics is a new area that we are proud to be leading. Skunk Family 19 Orange Family 21 The foundation of our success is the genetic control we have over our strains and the constant influx of new genetics that we obtain Blue Family 24 worldwide. -
Selling Cannabis Regulation: Learning from Ballot Initiatives in the United States in 2012
ISSN 2054-1910 Selling cannabis regulation: Learning From Ballot Initiatives in the United States in 2012 Emily Crick*, Mark Cooke¥ and Dave Bewley-Taylorp Policy Brief 6 | November 2014 Key Points • In November 2012, Washington, Colorado, and Oregon voted on ballot initiatives to establish legally regulated markets for the production, sale, use and taxation of cannabis.1 Washington and Colorado’s measures won by wide margins, while Oregon’s lost soundly. • A majority of voters view cannabis in a negative light, but also feel that prohibition for non-medical and non-scientific purposes is not working. As a result, they are more likely to support well-crafted reform policies that include strong regulations and direct tax revenue to worthy causes such as public health and education. • Ballot measures are not the ideal method for passing complicated pieces of legislation, but sometimes they are necessary for controversial issues. Other states often follow in their footsteps, including via the legislature. • The successful campaigns in Washington and Colorado relied on poll-driven messaging, were well organised, and had significant financing. The Oregon campaign lacked these elements. • The Washington and Colorado campaigns targeted key demographic groups, particularly 30-50 year old women, who were likely to be initially supportive of reform but then switch their allegiance to the ‘no’ vote. • Two key messages in Washington and Colorado were that legalisation, taxation and regulation will (i) free up scarce law enforcement resources to focus on more serious crimes and (ii) will create new tax revenue for worthy causes. • National attitudes on legalising cannabis are changing, with more and more people supporting reform. -
The Opportunities Party Real Deal Cannabis Reform
The Opportunities Party Real Deal Cannabis Reform PART 1: INTRODUCTION Our current drug law is outdated and not fit for purpose. The prohibition model set out under the Misuse of Drugs Act 1975 is a barrier for people seeking help if they need it. Drug addiction, like alcohol addiction tears families apart – but so does our drug law, which not only fails to protect people from harm, but actually adds to it.1 In overhauling this outdated Act The Opportunities Regular usage of cannabis is associated Party has developed an evidenced-based policy with health risk such as: that will more accurately reflect the internationally recognised intention of drug policy – to reduce harm. • problems with healthy brain development among youth; Assessing harm is an area that the current system • depression or anxiety injury; fails to effectively do. While the goal of the current • symptoms of chronic bronchitis;2 criminalisation policy is harm-minimisation based on the familiar strategies of controlling supply, However as with alcohol and cigarettes, reducing demand and limiting the problem – it fails abstinence is unrealistic. Prohibition flies in the to account for the effects of exposing users and face of popular demand and leads to illicit supply growers to gangs and to the criminal justice system. and usage.3 The evidence shows that criminalisation The evidence is mounting that these consequences of cannabis has had no significant statistical impact have greater detrimental impacts than those from on reducing use, nor is there any evidence that cannabis use itself. The criminalisation approach decriminalisation increases use.4, 5, 6, 7 The health also ties up criminal justice resources that could risks listed above are still prevalent with or without be more effectively directed elsewhere. -
Considering Marijuana Legalization
Research Report Considering Marijuana Legalization Insights for Vermont and Other Jurisdictions Jonathan P. Caulkins, Beau Kilmer, Mark A. R. Kleiman, Robert J. MacCoun, Gregory Midgette, Pat Oglesby, Rosalie Liccardo Pacula, Peter H. Reuter C O R P O R A T I O N For more information on this publication, visit www.rand.org/t/rr864 Published by the RAND Corporation, Santa Monica, Calif. © Copyright 2015 RAND Corporation R® is a registered trademark. Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. Support RAND Make a tax-deductible charitable contribution at www.rand.org/giving/contribute www.rand.org Preface Marijuana legalization is a controversial and multifaceted issue that is now the subject of seri- ous debate. In May 2014, Governor Peter Shumlin signed Act 155 (S. -
Pink Floyd Amsterdam Coffeeshop
Pink floyd amsterdam coffeeshop Review of Amsterdam coffeeshop Pink Floyd, including atmosphere, pictures, contact, address, feeling and tips for visitors. Pink Floyd was a powerhouse of a coffeeshop in the good old daze of Amsterdam's 90's and naughties! Dampkring 2 is one of my favorite coffeeshops in Amsterdam for many reasons. It's still the same shop, still called Pink Floyd, but with the Dampkring menu. Years ago, Pink Floyd Coffeeshop was considered by many to be one of the best in all of Amsterdam. And while the quality of the service and. 2 reviews of Pink Floyd - CLOSED "This is my favourite coffee shop in the Recommended Reviews for Pink Floyd Best of Yelp Amsterdam – Coffee & Tea. Pink Floyd Coffeeshop. likes · 83 talking about this · were here. 64 Mohamed al Mokled st. right after AWLAD RAGAB Mostafa Alnahas themed. sitting at pink floyd coffeeshop amsterdam smoking. Coffeeshop Amsterdam is the best coffee shop in Amsterdam to truly experience the dutch cannabis culture. Modern interior with extensive menu & great music! Online menus from Coffeeshop Pink Floyd in Amsterdam Netherlands. Pink Floyd was bang opposite our hotel. it was our 1st and last stop . Went to Amsterdam twice and both times my first stop was the Pink Floyd Coffeeshop! great coffeshop! pink floyd album artwork all over the walls. very friendly staff,knowledgable weed men. One of the musts in the Amsterdam coffeeshop scene. then try Pink Floyd's Ummagumma. lol or Zappa on low.. if Dekuil turned it up There really aren't any coffee shops in the Amsterdam centrum and fringe areas. -
The Development of International Drug Control: Lessons Learned and Strategic Challenges for the Future
THE DEVELOPMENT OF INTERNATIONAL DRUG CONTROL: LESSONS LEARNED AND STRATEGIC CHALLENGES FOR THE FUTURE Martin Jelsma * Working Paper Prepared for the First Meeting of the Commission Geneva, 24-25 January 2011 * Martin Jelsma coordinates the Drugs & Democracy programme at the Transnational Institute (TNI) in The Netherlands. He contributed two support papers to the Latin American Commission on Drugs and Democracy: “The current state of drug policy debate. Trends in the last decade in the European Union and United Nations”, April 2008; and “Legislative Innovation in Drug Policy”, October 2009. The original English text was edited by David Aronson. 1 Abstract The emergence of more pragmatic and less punitive approaches to the drugs issue may represent the beginning of change in the current global drug control regime. The spread of HIV/AIDS among injecting drug users, the overcrowding of prisons, the reluctance in South America to remain a theatre for military anti-drug operations, and the ineffectiveness of repressive anti-drug efforts to reduce the illicit market have all contributed to the global erosion of support for the United States-style war on drugs. Over the last decade rapidly widening cracks have begun to split global drug control consensus. The zero-tolerance ideology is increasingly challenged by calls for decriminalisation, harm reduction and embedding human rights principles in drug control. And in recent years the merits of a regulated legal market for cannabis has been accepted as part of the mainstream debate about a more effective control model. This paper describes how the foundations for the global control system were established, the radicalization of the system toward more repressive implementation, consequently leading to soft defections and de-escalation efforts becoming more widespread; and in the last section projects a future for the ongoing reform process toward a modernization and humanization of the control system’s international legal framework as laid down in the UN drug control conventions. -
1.3 Cannabis Market
1.3 Cannabis market 1.3.1 Summary trend overview 1.3.2 Production UNODC estimates that between 200,000-641,800 ha The total estimated area for outdoor production of can- were used for outdoor cannabis cultivation in 2008. nabis in 2008 ranges from 200,000-641,800 ha. The There are high levels of uncertainty in cultivation esti- total cannabis herb production is estimated to range mates as cannabis can be grown - indoors or outdoors - from 13,300-66,100 mt and the production of cannabis in most countries in the world. Therefore, it is not resin from 2,200-9,900 mt. Due to high levels of uncer- possible to produce more precise data, as is done for tainty in estimating cultivation, it is not possible to opiates and cocaine. The total cannabis herb production produce more precise data, as is done for opiates and is estimated to range from 13,300-66,100 mt, and for coca/cocaine. cannabis resin, the estimated production range is 2,200- 9,900 mt. This chapter shows the information that is available and gives an indication of the extent of global cannabis cul- Total cannabis herb seizures increased somewhat in 2007 tivation and production. Minimum and maximum to reach a total of 5,600 mt. As in 2006, the majority of levels of production and cultivation are explored by cannabis herb seizures in 2007 were reported from applying four methods. One method is based on reported Mexico and the USA. Cannabis resin seizures also cultivation and production, the second is based on sei- increased to some 1,300 mt, with most seizures reported zures of cannabis, and the third and fourth method are by countries in West and Central Europe. -
CANNABIS CONSUMPTION AREAS (WHMC 5.70.041) Business Name
CANNABIS CONSUMPTION AREA BUSINESS LICENSE APPLICATION Department of Public Works 8300 Santa Monica Boulevard West Hollywood, CA 90069 (323) 848-6375 Cannabis Consumption Area with On-Site Adult-Use Retail shall mean and include: a licensed premise where cannabis may be purchased (for on-site consumption only) and consumed by persons 21 years of age and over. A cannabis consumption area must be limited to one of the following uses: 1. Consumption of cannabis by smoking, vaping, and ingesting edible products. 2. Consumption of cannabis edible products by ingestion only. Only the top eight scoring applicants in the Cannabis Consumption Area Business License category, as determined by the Screening Application process outlined in WHMC 5.70.035, and adopted by the Application Evaluation Committee on February 7, 2019, are eligible to apply for an Cannabis Consumption Area Business License with the City of West Hollywood and shall use the following application packet to apply: SUBMIT THE FOLLOWING ITEMS. Failure to submit the required information will constitute an incomplete application and will not be accepted by the Department of Public Works. Smoking, Vaping, Edibles Edibles Only Application Checklist Forms Included in the Application Packet Items to be Provided by the Applicant Provided N/A Completed Applicant/Owner Information Form Valid Government-issued ID or Drivers License (for all owners as defined in Section C)5 Acknowledgement of Operating Requirements California State Cannabis License (if already obtained) Cannabis Business Indemnity Agreement Form Detailed Business Floor Plan Agency Approvals for Issuance of Final License Neighborhood Layout (Elevations and Overhead)4 Notarized Owner's Affidavit Interior and Exterior Design Renderings1 Additional Information Requested Odor Control Plan Completed Request for Live Scan Service for all owners (as defined in Section C)5 and managers Approved Hazard Analysis Plan (if required)3 Live Scan Results Release Authorization Form Security Operations Plan1,2 Proof of Business Ownership (i.e.